| Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury A Gaudin, M Yemisci, H Eroglu, S Lepetre-Mouelhi, OF Turkoglu, ... Nature nanotechnology 9 (12), 1054-1062, 2014 | 240 | 2014 |
| Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections N Semiramoth, CD Meo, F Zouhiri, F Said-Hassane, S Valetti, R Gorges, ... ACS nano 6 (5), 3820-3831, 2012 | 138 | 2012 |
| Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor S Valetti, F Maione, S Mura, B Stella, D Desmaële, M Noiray, J Vergnaud, ... Journal of controlled release 192, 29-39, 2014 | 62 | 2014 |
| Peptide conjugation: before or after nanoparticle formation? S Valetti, S Mura, M Noiray, S Arpicco, F Dosio, J Vergnaud, D Desmaele, ... Bioconjugate chemistry 25 (11), 1971-1983, 2014 | 44 | 2014 |
| Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice S Valetti, S Mura, B Stella, P Couvreur Journal of nanobiotechnology 11, 1-17, 2013 | 42 | 2013 |
| Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections S Valetti, X Xia, J Costa-Gouveia, P Brodin, MF Bernet-Camard, ... Nanomedicine 12 (8), 831-844, 2017 | 37 | 2017 |
| Multivalent mesoporous silica nanoparticles photo-delivering nitric oxide with carbon dots as fluorescence reporters D Afonso, S Valetti, A Fraix, C Bascetta, S Petralia, S Conoci, A Feiler, ... Nanoscale 9 (36), 13404-13408, 2017 | 32 | 2017 |
| Cyclodextrin-mesoporous silica particle composites for controlled antibiotic release. A proof of concept toward colon targeting L Stjern, S Voittonen, R Weldemichel, S Thuresson, M Agnes, ... International Journal of Pharmaceutics 531 (2), 595-605, 2017 | 20 | 2017 |
| Synthesis and Cytotoxic Activity of Self‐Assembling Squalene Conjugates of 3‐[(Pyrrol‐2‐yl)methylidene]‐2,3‐dihydro‐1H‐indol‐2‐one Anticancer Agents E Buchy, S Valetti, S Mura, J Mougin, C Troufflard, P Couvreur, ... European Journal of Organic Chemistry 2015 (1), 202-212, 2015 | 19 | 2015 |
| Mesoporous silica particles as a lipophilic drug vehicle investigated by fluorescence lifetime imaging S Valetti, J Wankar, MB Ericson, A Feiler, I Manet Journal of materials chemistry B 5 (17), 3201-3211, 2017 | 17 | 2017 |
| Fluorescence imaging of antibiotic clofazimine encapsulated within mesoporous silica particle carriers: Relevance to drug delivery and the effect on its release kinetics L Angiolini, S Valetti, B Cohen, A Feiler, A Douhal Physical Chemistry Chemical Physics 20 (17), 11899-11911, 2018 | 16 | 2018 |
| Can mesoporous nanoparticles promote bioavailability of topical pharmaceutics? S Valetti, H Thomsen, J Wankar, P Falkman, I Manet, A Feiler, MB Ericson, ... International Journal of Pharmaceutics 602, 120609, 2021 | 14 | 2021 |
| Bare and effective charge of mesoporous silica particles S Valetti, A Feiler, M Trulsson Langmuir 33 (29), 7343-7351, 2017 | 11 | 2017 |
| Targeted photodynamic therapy with a folate/sensitizer assembly produced from mesoporous silica C Zhou, D Afonso, S Valetti, A Feiler, V Cardile, ACE Graziano, S Conoci, ... Chemistry–A European Journal 23 (32), 7672-7676, 2017 | 10 | 2017 |
| In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better S Mura, E Buchy, G Askin, F Cayre, J Mougin, S Gouazou, D Sobot, ... Biochimie 130, 4-13, 2016 | 10 | 2016 |
| Oral transmucosal delivery of eletriptan for neurological diseases S Valetti, A Riaz, A Doko, K Sultana, M Eskandari, Z Prgomet, A Feiler, ... International Journal of Pharmaceutics 627, 122222, 2022 | 4 | 2022 |
| A novel versatile flow-donor chamber as biorelevant ex-vivo test assessing oral mucoadhesive formulations S Gidvall, S Björklund, A Feiler, B Dahlström, R Rönn, J Engblom, ... European Journal of Pharmaceutical Sciences 166, 105983, 2021 | 4 | 2021 |
| Three-dimensional oral mucosal equivalents as models for transmucosal drug permeation studies A Riaz, S Gidvall, Z Prgomet, AR Hernandez, T Ruzgas, EJ Nilsson, ... Pharmaceutics 15 (5), 1513, 2023 | 3 | 2023 |
| Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis JEC Pacheco, T Yalovenko, A Riaz, N Kotov, C Davids, A Persson, ... Journal of Controlled Release 369, 231-250, 2024 | | 2024 |
| Cell viability and inflammatory responses of amorphous mesoporous silica particles on different macrophage cells T Yalovenko, JE Campos Pacheco, E Schousboe, A Gustafsson, ... Journal of Aerosol Medicine 36 (6), A37-A38, 2023 | | 2023 |
